# Contribution of UGT2B17 to the Pharmacokinetics of Diclofenac

> **NCT06053411** · EARLY_PHASE1 · RECRUITING · sponsor: **Washington State University** · enrollment: 30 (estimated)

## Conditions studied

- Interaction

## Interventions

- **DRUG:** Diclofenac
- **DIETARY_SUPPLEMENT:** curcumin

## Key facts

- **NCT ID:** NCT06053411
- **Lead sponsor:** Washington State University
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-03-01
- **Primary completion:** 2025-12-18
- **Final completion:** 2026-08-18
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2024-11-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06053411

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06053411, "Contribution of UGT2B17 to the Pharmacokinetics of Diclofenac". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06053411. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*